Rifampicin-resistant tuberculosis (RR-TB), MSF clinical trials present short and effective treatment
Rifampicin-resistant tuberculosis (RR-TB): TB-PRACTECAL, a clinical trial led by Médecins Sans Frontières (MSF), has found that a new, all-oral, six-month treatment regimen is safer and more effective at treating rifampicin-resistant…